Evidence check: Östradiol in the context of Langlebigkeit

The role of estradiol in the context of longevity is not yet fully resolved. Estradiol, the primary form of estrogen, influences numerous physiological processes – from bone metabolism and cardiovascular health to cognitive function. In women, estradiol levels drop sharply after menopause, which is associated with increased risks of osteoporosis, cardiovascular disease, and possibly accelerated biological aging. Some observational studies suggest a link between higher postmenopausal estradiol levels and lower all-cause mortality, but results are inconsistent. In men, the evidence is even weaker; estradiol plays a role in bone density and libido, but a clear longevity benefit is lacking. Importantly, estradiol is measured via blood or saliva tests, not through DNA analysis. Hormone replacement therapy (HRT) with estradiol may offer benefits but also carries risks (e.g., breast cancer, thrombosis) – individual risk-benefit assessment is crucial. Consumer tests measuring estradiol provide only a snapshot and do not replace medical diagnostics. Evidence level: human-moderate (observational studies, some RCTs) to mixed. No specific sources from the provided context.